Literature DB >> 32931123

Delivering on the public health promise of the psychosis risk paradigm.

Tyrone D Cannon1.   

Abstract

Entities:  

Year:  2020        PMID： 32931123      PMCID： PMC7491612          DOI： 10.1002/wps.20785

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.

Authors:  Alison R Yung; Hok Pan Yuen; Patrick D McGorry; Lisa J Phillips; Daniel Kelly; Margaret Dell'Olio; Shona M Francey; Elizabeth M Cosgrave; Eoin Killackey; Carrie Stanford; Katherine Godfrey; Joe Buckby
Journal:  Aust N Z J Psychiatry       Date:  2005 Nov-Dec       Impact factor: 5.744

3.  North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment.

Authors:  Jean Addington; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Jack A Addington; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2012-10-06       Impact factor: 4.939

Review 4.  The prodromal phase of first-episode psychosis: past and current conceptualizations.

Authors:  A R Yung; P D McGorry
Journal:  Schizophr Bull       Date:  1996       Impact factor: 9.306

5.  Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.

Authors:  Jean Addington; Jacqueline Stowkowy; Lu Liu; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Olga Santesteban-Echarri; Scott W Woods
Journal:  Psychol Med       Date:  2018-09-04       Impact factor: 7.723

6.  Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: outcomes to 36-months.

Authors:  Amanda L Baker; David J Kavanagh; Frances J Kay-Lambkin; Sally A Hunt; Terry J Lewin; Vaughan J Carr; Patrick McElduff
Journal:  J Subst Abuse Treat       Date:  2013-10-14

7.  An Individualized Risk Calculator for Research in Prodromal Psychosis.

Authors:  Tyrone D Cannon; Changhong Yu; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Robert Heinssen; Clark D Jeffries; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Michael W Kattan
Journal:  Am J Psychiatry       Date:  2016-07-01       Impact factor: 18.112

8.  Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

Authors:  Tyrone D Cannon; Yoonho Chung; George He; Daqiang Sun; Aron Jacobson; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Clark Jeffries; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen
Journal:  Biol Psychiatry       Date:  2014-06-12       Impact factor: 13.382

9.  Self-awareness of functional impairment in individuals at clinical high-risk for psychosis.

Authors:  Doreen M Olvet; Ricardo E Carrión; Andrea M Auther; Barbara A Cornblatt
Journal:  Early Interv Psychiatry       Date:  2013-08-22       Impact factor: 2.732
  9 in total
  1 in total

1.  Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study.

Authors:  Giammarco Cascino; Rossella Ceres; Alessio Maria Monteleone; Paola Bucci; Giulia Maria Giordano; Silvana Galderisi; Palmiero Monteleone
Journal:  J Clin Med       Date:  2022-10-10       Impact factor: 4.964
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.